G L Krauss1, N R Miller. Show Affiliations » 1. Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Abstract
Entities: Disease
Mesh: See more » Anticonvulsants/adverse effectsAnticonvulsants/therapeutic useEpilepsy/complicationsEpilepsy/drug therapyHumansRisk FactorsVigabatrin/adverse effectsVigabatrin/therapeutic useVision Disorders/chemically induced
Substances: See more » AnticonvulsantsVigabatrin
Year: 1999 PMID: 10630838 DOI: 10.1345/aph.19308
Source DB: PubMed Journal: Ann Pharmacother ISSN: 1060-0280 Impact factor: 3.154